Nektar Therapeutics
NKTR
#7605
Rank
ยฃ0.19 B
Marketcap
ยฃ1.08
Share price
2.19%
Change (1 day)
174.47%
Change (1 year)

Revenue for Nektar Therapeutics (NKTR)

Revenue in 2024 (TTM): ยฃ74.24 Million

According to Nektar Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ71.75 Million. In 2023 the company made a revenue of ยฃ70.73 Million a decrease over the revenue in the year 2022 that were of ยฃ76.09 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nektar Therapeutics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ74.24 M4.96%
2023 ยฃ70.73 M-7.03%
2022 ยฃ76.09 M0.79%
2021 ยฃ75.49 M-32.7%
2020 ยฃ0.11 B28.35%
2019 ยฃ87.4 M-90.7%
2018 ยฃ0.94 B312.9%
2017 ยฃ0.22 B69.81%
2016 ยฃ0.13 B-13.91%
2015 ยฃ0.15 B20.8%
2014 ยฃ0.12 B42.79%
2013 ยฃ90.28 M79.73%
2012 ยฃ50.23 M9.23%
2011 ยฃ45.98 M-55.36%
2010 ยฃ0.10 B131.77%
2009 ยฃ44.45 M-27.76%
2008 ยฃ61.53 M-55.23%
2007 ยฃ0.13 B23.65%
2006 ยฃ0.11 B51.79%
2005 ยฃ73.22 M23.03%
2004 ยฃ59.52 M0.2%
2003 ยฃ59.4 M0.42%
2002 ยฃ59.15 M10.71%
2001 ยฃ53.42 M54.46%
2000 ยฃ34.59 M35.07%
1999 ยฃ25.61 M95.23%
1998 ยฃ13.11 M32.61%
1997 ยฃ9.89 M145.47%
1996 ยฃ4.02 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ25.06 B 34,823.84%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.85 B 59,629.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ48.12 B 66,968.50%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.15 B 112.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ37.84 B 52,642.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ11.55 B 15,998.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.15 B 1,515.68%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ67.55 B 94,037.85%๐Ÿ‡บ๐Ÿ‡ธ USA